SCHEMBL6980833

SCHEMBL6980833

CCC(OC(N)=O)C(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.43
TSHR P16473 3/20 0.43
CHRM2 P08172 1/20 0.43
CHRM4 P08173 1/20 0.43
CHRM5 P08912 1/20 0.43
CHRM1 P11229 1/20 0.43
CHRM3 P20309 1/20 0.43
CYP2C9 P11712 1/20 0.43
MAPT P10636 1/20 0.42
ALOX15 P16050 1/20 0.39
HSD17B10 Q99714 1/20 0.33
CHRNB2 P17787 1/20 0.32
CHRNB4 P30926 1/20 0.32
CHRNA3 P32297 1/20 0.32
CHRNA4 P43681 1/20 0.32
CYP3A4 P08684 1/20 0.32
NFKB1 P19838 1/20 0.32
ADRA1A P35348 1/20 0.32
RAB9A P51151 1/20 0.32
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29728562 0.87 ALOX15 (0.43) LMNATSHRCHRM2CHRM4CHRM5
SCHEMBL29728555 0.85 LMNA (0.39) LMNATSHRCHRM2CHRM4CHRM5
SCHEMBL6671730 0.84 LMNA (0.42) LMNATSHRCHRM2CHRM4CHRM5
SCHEMBL29728540 0.84 LMNA (0.42) LMNATSHRCHRM2CHRM4CHRM5
SCHEMBL17510954 0.82 LMNA (0.41) LMNATSHRCHRM2CHRM4CHRM5
SCHEMBL30889149 0.81 CHRM2 (0.30) LMNATSHRCHRM2CHRM4CHRM5
SCHEMBL28553823 0.81 LMNA (0.43) LMNATSHRCHRM2CHRM4CHRM5
SCHEMBL28094755 0.81 LMNA (0.43) LMNATSHRCHRM2CHRM4CHRM5
SCHEMBL28330536 0.81 LMNA (0.43) LMNATSHRCHRM2CHRM4CHRM5
SCHEMBL18596831 0.80 LMNA (0.39) LMNATSHRCHRM2CHRM4CHRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109689664-A The quinoline and azepine quinoline compound that tricyclic heteroaryl as PAR4 inhibitor replaces 百时美施贵宝公司 2019-04-26 CN claimed
CN-109689664-A The quinoline and azepine quinoline compound that tricyclic heteroaryl as PAR4 inhibitor replaces 百时美施贵宝公司 2019-04-26 CN disclosed
EP-0934938-B1 SUBSTITUTED BENZOYLAMINOTHIAZOLE DERIVATIVES AND DRUGS CONTAINING THE SAME ZERIA PHARM CO LTD (JP) 2003-01-15 EP disclosed
EP-0934938-A1 SUBSTITUTED BENZOYLAMINOTHIAZOLE DERIVATIVES AND DRUGS CONTAINING THE SAME ZERIA PHARMACEUTICAL CO., LTD. (JP) 1999-08-11 EP disclosed